Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA3 | P51812 | 7/20 | 0.51 |
| ▸ | BTK | Q06187 | 4/20 | 0.48 |
| ▸ | JAK3 | P52333 | 3/20 | 0.48 |
| ▸ | WEE1 | P30291 | 3/20 | 0.47 |
| ▸ | SRC | P12931 | 2/20 | 0.47 |
| ▸ | GSK3A | P49840 | 3/20 | 0.46 |
| ▸ | GSK3B | P49841 | 3/20 | 0.46 |
| ▸ | AURKA | O14965 | 2/20 | 0.46 |
| ▸ | FLT3 | P36888 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16245564 | 0.99 | RPS6KA3 (0.50) | RPS6KA3BTKJAK3WEE1SRC | |
| SCHEMBL17827722 | 0.97 | RPS6KA3 (0.52) | RPS6KA3BTKJAK3WEE1SRC | |
| Hydrochloric Acid SCHEMBL16245574 | 0.96 | RPS6KA3 (0.51) | RPS6KA3BTKJAK3WEE1SRC | |
| SCHEMBL17827725 | 0.94 | RPS6KA3 (0.56) | RPS6KA3BTKJAK3WEE1SRC | |
| Hydrochloric Acid SCHEMBL16245583 | 0.93 | RPS6KA3 (0.55) | RPS6KA3BTKJAK3WEE1SRC | |
| SCHEMBL16245546 | 0.91 | RPS6KA3 (0.57) | RPS6KA3BTKJAK3WEE1SRC | |
| SCHEMBL16264829 | 0.87 | RPS6KA3 (0.52) | RPS6KA3BTKJAK3WEE1SRC | |
| SCHEMBL16264903 | 0.86 | RPS6KA3 (0.47) | RPS6KA3BTKJAK3GSK3AGSK3B | |
| SCHEMBL16264847 | 0.85 | JAK2 (0.47) | RPS6KA3BTKJAK3WEE1SRC | |
| Hydrochloric Acid SCHEMBL16245600 | 0.85 | JAK2 (0.46) | RPS6KA3BTKJAK3WEE1SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9861635-B2 | Macrocycles as kinase inhibitors | MERCK PATENT GMBH (DE) | 2018-01-09 | — | — | US | disclosed |
| US-20160166574-A1 | MACROCYCLES AS KINASE INHIBITORS | MERCK PATENT GMBH (DE) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166574-A1 | MACROCYCLES AS KINASE INHIBITORS | EIF2AK4, CDK2, CDK1 | RPS6KA3 19/4885BTK 269/4885JAK3 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.